Annual Accounts Receivable
$47.84 M
+$7.49 M+18.56%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual accounts receivable is $47.84 million, with the most recent change of +$7.49 million (+18.56%) on December 31, 2023.
- During the last 3 years, PBYI annual accounts receivable has risen by +$22.29 million (+87.28%).
- PBYI annual accounts receivable is now at all-time high.
Performance
PBYI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$54.64 M
+$26.54 M+94.42%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly accounts receivable is $54.64 million, with the most recent change of +$26.54 million (+94.42%) on September 30, 2024.
- Over the past year, PBYI quarterly accounts receivable has increased by +$25.67 million (+88.59%).
- PBYI quarterly accounts receivable is now -32.53% below its all-time high of $80.98 million, reached on March 31, 2019.
Performance
PBYI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
PBYI Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.6% | +88.6% |
| 3 y3 years | +87.3% | +60.8% |
| 5 y5 years | +130.3% | +60.8% |
PBYI Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +47.1% | at high | +122.3% |
| 5 y | 5-year | at high | +87.3% | at high | +129.6% |
| alltime | all time | at high | -100.0% | -32.5% | -100.0% |
Puma Biotechnology Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $54.64 M(+94.4%) |
| Jun 2024 | - | $28.11 M(+14.3%) |
| Mar 2024 | - | $24.58 M(-48.6%) |
| Dec 2023 | $47.84 M(+18.6%) | $47.84 M(+65.1%) |
| Sep 2023 | - | $28.97 M(-7.4%) |
| Jun 2023 | - | $31.29 M(+0.4%) |
| Mar 2023 | - | $31.16 M(-22.8%) |
| Dec 2022 | $40.35 M(+24.1%) | $40.35 M(+44.0%) |
| Sep 2022 | - | $28.03 M(-17.5%) |
| Jun 2022 | - | $33.99 M(+25.7%) |
| Mar 2022 | - | $27.04 M(-16.9%) |
| Dec 2021 | $32.53 M(+27.3%) | $32.53 M(+36.7%) |
| Sep 2021 | - | $23.80 M(-22.1%) |
| Jun 2021 | - | $30.55 M(+16.8%) |
| Mar 2021 | - | $26.16 M(+2.4%) |
| Dec 2020 | $25.54 M | $25.54 M(-5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $27.14 M(+13.1%) |
| Jun 2020 | - | $23.99 M(-24.0%) |
| Mar 2020 | - | $31.54 M(+9.2%) |
| Dec 2019 | $28.90 M(+39.1%) | $28.90 M(+6.3%) |
| Sep 2019 | - | $27.18 M(+7.2%) |
| Jun 2019 | - | $25.35 M(-68.7%) |
| Mar 2019 | - | $80.98 M(+289.9%) |
| Dec 2018 | $20.77 M(+114.8%) | $20.77 M(+5.2%) |
| Sep 2018 | - | $19.75 M(-7.5%) |
| Jun 2018 | - | $21.34 M(+30.9%) |
| Mar 2018 | - | $16.31 M(+68.7%) |
| Dec 2017 | $9.67 M(>+9900.0%) | $9.67 M(+148.6%) |
| Sep 2017 | - | $3.89 M(>+9900.0%) |
| Dec 2016 | $0.00 | $0.00(-100.0%) |
| Sep 2016 | - | $1.18 M(0.0%) |
| Jun 2016 | - | $1.18 M |
FAQ
- What is Puma Biotechnology annual accounts receivable?
- What is the all time high annual accounts receivable for Puma Biotechnology?
- What is Puma Biotechnology annual accounts receivable year-on-year change?
- What is Puma Biotechnology quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Puma Biotechnology?
- What is Puma Biotechnology quarterly accounts receivable year-on-year change?
What is Puma Biotechnology annual accounts receivable?
The current annual accounts receivable of PBYI is $47.84 M
What is the all time high annual accounts receivable for Puma Biotechnology?
Puma Biotechnology all-time high annual accounts receivable is $47.84 M
What is Puma Biotechnology annual accounts receivable year-on-year change?
Over the past year, PBYI annual accounts receivable has changed by +$7.49 M (+18.56%)
What is Puma Biotechnology quarterly accounts receivable?
The current quarterly accounts receivable of PBYI is $54.64 M
What is the all time high quarterly accounts receivable for Puma Biotechnology?
Puma Biotechnology all-time high quarterly accounts receivable is $80.98 M
What is Puma Biotechnology quarterly accounts receivable year-on-year change?
Over the past year, PBYI quarterly accounts receivable has changed by +$25.67 M (+88.59%)